Derniers ajouts - CRVO 25 year old man - Factor V Leiden Heterozygous 25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 403 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 470 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 436 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 438 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 401 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 383 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 405 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 461 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 405 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 418 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 445 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 427 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 419 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 407 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 417 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 417 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 426 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 429 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 507 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 424 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 464 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 405 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 468 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 417 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvu 539 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.18 Décembre 2018
|
|
|
|
|
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy
